Pascal Rigollier

1.5k citations

15 papers · 515 indexed · h-index 11

Impact in

Endocrine and Autonomic Systems top 5%
- Regulation of Appetite and Obesity
Cellular and Molecular Neuroscience top 10%
- Neuropeptides and Animal Physiology

Papers in ⓘ

Toxicology 1
Organic Chemistry 6
- Asymmetric Synthesis and Catalysis 3
- Synthetic Organic Chemistry Methods 3
- Chemical synthesis and alkaloids 2
- Oxidative Organic Chemistry Reactions 2

Co-authors: Yasuchika Yamaguchi (4 shared papers)Walter Schilling (4 shared papers)Steven Whitebread (3 shared papers)Michele Chiesi (2 shared papers)Leoluca Criscione (2 shared papers)Mary W. Walker (2 shared papers)Philip Magnus (3 shared papers)Rainer O. Heurich (1 shared paper)
Journals: Journal of the American Chemical Society (3 papers)Journal of Medicinal Chemistry (3 papers)Tetrahedron Letters (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)SLAS DISCOVERY (1 paper)
Partner nations: Switzerland United States Austria

In The Last Decade

Pascal Rigollier

15 papers receiving 497 citations

Peers

Countries citing papers authored by Pascal Rigollier

Since Specialization

Citations

This map shows the geographic impact of Pascal Rigollier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Rigollier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Rigollier more than expected).

Fields of papers citing papers by Pascal Rigollier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Rigollier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Rigollier. The network helps show where Pascal Rigollier may publish in the future.

Co-authors

The 25 scholars most cited alongside Pascal Rigollier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pascal Rigollier Line = papers co-authored together Pascal Rigollier links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work
1	Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor. Journal of Clinical Investigation ·Leoluca Criscione, Pascal Rigollier, Christine Batzl‐Hartmann, H. Rüeger, Alain Stricker‐Krongrad, P Wyss, L. Brunner, Steven Whitebread, Yasuchika Yamaguchi, Christophe Gerald, Rainer O. Heurich, Mary W. Walker, Michele Chiesi, Walter Schilling, Karl G. Hofbauer, N Levens	1998	183
2	Structural Modification of the P2‘ Position of 2,7-Dialkyl-Substituted 5( S )-Amino-4( S )-hydroxy-8-phenyl-octanecarboxamides: The Discovery of Aliskiren, a Potent Nonpeptide Human Renin Inhibitor Active after Once Daily Dosing in Marmosets Journal of Medicinal Chemistry ·Jürgen Maibaum, Stefan Stutz, Richard Göschke, Pascal Rigollier, Yasuchika Yamaguchi, Frédéric Cumin, Joseph Rahuel, Hans-Peter Baum, Nissim-Claude Cohen, Christian Schnell, Walter Fuhrer, M.G. Gruetter, Walter Schilling, Jeanette M. Wood	2007	67
3	Key Aspects of the Novartis Compound Collection Enhancement Project for the Compilation of a Comprehensive Chemogenomics Drug Discovery Screening Collection Current Topics in Medicinal Chemistry ·Edgar Jacoby, Ansgar Schuffenhauer, Maxim Popov, Khalil Azzaoui, Benjamin Havill, Ulrich Schopfer, Caroline Engeloch, Jaroslav Staněk, Pierre Acklin, Pascal Rigollier, Friederike Stoll, Guido Koch, Peter Meier, David Orain, Rudolph Giger, Jurgen Hinrichs, Karine Malagu, Jurg Zimmermann, H.‐J. ROTH	2005	51
4	Design, synthesis and SAR of a series of 2-substituted 4-amino-quinazoline neuropeptide Y Y5 receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Heinrich Rueeger, Pascal Rigollier, Yasuchika Yamaguchi, Tibur Schmidlin, Walter Schilling, Leoluca Criscione, Steven Whitebread, Michele Chiesi, Mary W. Walker, Dale Dhanoa, Imadul Islam, Jack Zhang, Charles Gluchowski	2000	37
5	Novel 2,7-Dialkyl-Substituted 5(S)-Amino-4(S)-hydroxy-8-phenyl-octanecarboxamide Transition State Peptidomimetics Are Potent and Orally Active Inhibitors of Human Renin Journal of Medicinal Chemistry ·Richard Göschke, Stefan Stutz, Vittorio Rasetti, Nissim-Claude Cohen, Joseph Rahuel, Pascal Rigollier, Hans-Peter Baum, Peter Forgiarini, Christian Schnell, Trixie Wagner, M.G. Gruetter, Walter Fuhrer, Walter Schilling, Frédéric Cumin, Jeanette M. Wood, Jürgen Maibaum	2007	34
6	Fragment-Based Screening by Biochemical Assays: Systematic Feasibility Studies with Trypsin and MMP12 SLAS DISCOVERY ·Andreas Boettcher, Simon Ruedisser, P. Erbel, D. Vinzenz, Nikolaus Schiering, Ulrich Hassiepen, Pascal Rigollier, Lorenz M. Mayr, Julian Woelcke	2010	29
7	Regioselective cyclopentane ring formation mediated by titanocene chloride Journal of the American Chemical Society ·Pascal Rigollier, Jonathan R. Young, Lissa A. Fowley, John R. Stille	1990	27
8	Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In Vivo Journal of Medicinal Chemistry ·Juraj Velcicky, Ursula Bodendorf, Pascal Rigollier, Robert Epple, Daniel R. Beisner, Danilo Guerini, Philip L. Smith, Bo Liu, Roland Feifel, Peter Wipfli, Reiner Aichholz, Philippe Couttet, Ina Dix, Toni Widmer, Ben G. Wen, Trixi Brandl	2018	20
9	Applications of the β-Azidonation Reaction to Organic Synthesis. α,β-Enones, Conjugate Addition, and γ-Lactam Annulation Journal of the American Chemical Society ·Philip Magnus, Jérôme Lacour, P. Andrew Evans, Pascal Rigollier, Hans Tobler	1998	20
10	Discovery and SAR of potent, orally available and brain-penetrable 5,6-dihydro-4H-3-thia-1-aza-benzo[e]azulen- and 4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen derivatives as neuropeptide Y Y5 receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Heinrich Rueeger, Marc Gerspacher, Peter Buehlmayer, Pascal Rigollier, Yasuchika Yamaguchi, Tibur Schmidlin, Steven Whitebread, Barbara Nuesslein‐Hildesheim, Hanspeter Nick, Leoluca Cricione	2004	16
11	New mild methodology for the synthesis of α-phenylthio and α-phenylseleno ketones Tetrahedron Letters ·Philip Magnus, Pascal Rigollier	1992	10
12	Discovery of Orally Active Hydroxyethylamine Based SPPL2a Inhibitors ACS Medicinal Chemistry Letters ·Juraj Velcicky, Casey J. N. Mathison, V. I. Nikulin, Daniel Pflieger, Robert Epple, Mihai Azimioara, Christopher Cow, Pierre‐Yves Michellys, Pascal Rigollier, Daniel R. Beisner, Ursula Bodendorf, Danilo Guerini, Bo Liu, Ben G. Wen, Samantha Zaharevitz, Trixi Brandl	2019	9
13	New trialkylsilyl enol ether chemistry: intramolecular [2 + 2] cyclizations of .beta.-amido triisopropylsilyl enol ethers Journal of the American Chemical Society ·Philip Magnus, Pascal Rigollier, Jérôme Lacour, Hans Tobler	1993	8
14	A facile synthesis of novel 2-amino-6-arylmethyl-7-carboxamido-7,8-dihydropyrimido[5,4-f][1,4]thiazepin-5-ones Tetrahedron Letters ·Lan-Ying Qin, Andrew G. Cole, Axel Metzger, Marc‐Raleigh Brescia, Kurt W. Saionz, Joan J. Zhang, Pascal Rigollier, James R. Wareing, Hubert Gstach, Juerg Zimmermann, Roland E. Dolle, John J. Baldwin, Ian Henderson	2010	3
15	ChemInform Abstract: Regioselective Cyclopentane Ring Formation Mediated by Titanocene Chloride. ChemInform ·Pascal Rigollier, Jonathan R. Young, Lissa A. Fowley, John R. Stille	1991	1

About Pascal Rigollier

Pascal Rigollier is a scholar working on Toxicology, Organic Chemistry, Computational Theory and Mathematics, Cellular and Molecular Neuroscience and Endocrine and Autonomic Systems, having authored 15 papers that have together received 515 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (4 papers), Asymmetric Synthesis and Catalysis (3 papers), Synthetic Organic Chemistry Methods (3 papers), Computational Drug Discovery Methods (3 papers), Neuropeptides and Animal Physiology (3 papers), Chemical synthesis and alkaloids (2 papers), Oxidative Organic Chemistry Reactions (2 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (2 papers). The work is most often cited by research in Endocrine and Autonomic Systems (122 citations), Cellular and Molecular Neuroscience (179 citations), Organic Chemistry (158 citations), Computational Theory and Mathematics (81 citations) and Molecular Biology (269 citations). Pascal Rigollier has collaborated with scholars based in Switzerland, United States and Austria. Frequent co-authors include Yasuchika Yamaguchi, Walter Schilling, Steven Whitebread, Michele Chiesi, Leoluca Criscione, Mary W. Walker, Philip Magnus, Rainer O. Heurich, Christophe Gerald and Christine Batzl‐Hartmann. Their work appears in journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry, Tetrahedron Letters, Bioorganic & Medicinal Chemistry Letters and SLAS DISCOVERY.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact